BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10747824)

  • 1. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
    das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC
    J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
    Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
    Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance.
    Yamazoe K; Kato N; Kato H; Tanaka K; Katagiri Y; Watanabe K
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2808-10. PubMed ID: 10543771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
    Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
    Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
    Jasemi S; Emaneini M; Ahmadinejad Z; Fazeli MS; Sechi LA; Sadeghpour Heravi F; Feizabadi MM
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):27. PubMed ID: 33892721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
    Jeverica S; Sóki J; Premru MM; Nagy E; Papst L
    Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.
    de Carvalho CB; Moreira JL; Ferreira MC
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):329-35. PubMed ID: 9293074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rosenblatt J; Venezia R; Gorbach SL; Queenan AM; Hecht DW
    Anaerobe; 2011 Aug; 17(4):147-51. PubMed ID: 21664469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Kawamoto Y; Kosai K; Ota K; Uno N; Sakamoto K; Hasegawa H; Izumikawa K; Mukae H; Yanagihara K
    Anaerobe; 2021 Dec; 72():102448. PubMed ID: 34537378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
    Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
    Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis.
    Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y
    Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
    Ogane K; Tarumoto N; Kodana M; Onodera A; Imai K; Sakai J; Kawamura T; Takeuchi S; Murakami T; Mitsutake K; Ikebuchi K; Maesaki S; Maeda T
    Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
    Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
    BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
    Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
    Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
    Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
    Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.